We are live on ! Find out more
TECH icon

Bio-Techne

248 hedge funds and large institutions have $2.6B invested in Bio-Techne in 2013 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 98 increasing their positions, 87 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 17

20% more capital invested

Capital invested by funds: $2.17B → $2.6B (+$430M)

13% more repeat investments, than reductions

Existing positions increased: 98 | Existing positions reduced: 87

6% more funds holding

Funds holding: 233248 (+15)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
248
Holders Change
+15
Holders Change %
+6.44%
% of All Funds
8.04%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
34
Increased
98
Reduced
87
Closed
17
Calls
$88K
Puts
Net Calls
+$88K
Net Calls Change
+$102K
Name Holding Trade Value Shares
Change
Change in
Stake
PPA
51
Parametric Portfolio Associates
Washington
$8.21M +$617K +32,532 +9%
RhumbLine Advisers
52
RhumbLine Advisers
Massachusetts
$8.12M -$983K -51,820 -11%
Deutsche Bank
53
Deutsche Bank
Germany
$7.95M +$3.43M +180,572 +83%
BIM
54
BlackRock Investment Management
Delaware
$7.75M +$396K +20,880 +6%
NFA
55
Nationwide Fund Advisors
Ohio
$7.51M +$2.41M +126,976 +51%
Fidelity Investments
56
Fidelity Investments
Massachusetts
$7.21M -$41K -2,160 -0.6%
California Public Employees Retirement System
57
California Public Employees Retirement System
California
$6.98M +$57.2K +3,012 +0.9%
SCM
58
Snyder Capital Management
California
$6.84M -$2.42M -127,360 -27%
Principal Financial Group
59
Principal Financial Group
Iowa
$6.72M +$159K +8,380 +3%
State Farm Mutual Automobile Insurance
60
State Farm Mutual Automobile Insurance
Illinois
$6.43M
EAM
61
Eagle Asset Management
Florida
$6.43M -$209K -11,032 -3%
First Trust Advisors
62
First Trust Advisors
Illinois
$6.4M +$5.14M +270,816 +554%
GC
63
Guggenheim Capital
Illinois
$6.31M +$4.65M +245,028 +349%
D.E. Shaw & Co
64
D.E. Shaw & Co
New York
$6.28M +$1.04M +54,556 +21%
Barclays
65
Barclays
United Kingdom
$6.15M +$280K +14,756 +5%
PAMP
66
Polar Asset Management Partners
Ontario, Canada
$5.86M +$2.67M +140,808 +93%
New York State Teachers Retirement System (NYSTRS)
67
New York State Teachers Retirement System (NYSTRS)
New York
$5.78M
AIG
68
American International Group
New York
$5.61M -$182K -9,592 -3%
Dimensional Fund Advisors
69
Dimensional Fund Advisors
Texas
$5.51M +$126K +6,640 +2%
Charles Schwab
70
Charles Schwab
California
$5.47M +$371K +19,544 +8%
California State Teachers Retirement System (CalSTRS)
71
California State Teachers Retirement System (CalSTRS)
California
$5.3M +$156K +8,208 +3%
CBOA
72
Commonwealth Bank of Australia
Australia
$5.29M +$849K +44,756 +20%
Bessemer Group
73
Bessemer Group
New Jersey
$5.29M +$5M +263,668 +70,124%
PAMU
74
Pictet Asset Management (UK)
United Kingdom
$5.24M -$2.18M -114,800 -30%
State of Wisconsin Investment Board
75
State of Wisconsin Investment Board
Wisconsin
$4.97M +$2.5M +131,640 +113%

TECH Hedge Fund Activity: Q3 2013 in Review

248 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q3 2013, worth a combined $2.6B — up 20% from $2.17B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new TECH positions and 17 closed out — a net gain of 17 holders — while 98 added to existing stakes and 87 trimmed.

The largest buyer was Schroder Investment Management Group, adding an estimated $27.2M. The largest seller was Champlain Investment Partners, cutting an estimated $17.5M.

  • 248 institutional investors held Bio-Techne (TECH) as of Q3 2013, up from 233 in Q2 2013.
  • Funds reported $2.6B of Bio-Techne stock for Q3 2013, up 20% quarter-over-quarter.
  • 34 funds opened new Bio-Techne positions in Q3 2013 and 17 closed out, a net change of +17 holders.
  • The largest Bio-Techne buyer in Q3 2013 was Schroder Investment Management Group, an estimated $27.2M added.
  • The largest Bio-Techne seller in Q3 2013 was Champlain Investment Partners, an estimated $17.5M sold.

Based on aggregated 13F filings for Q3 2013.